Free Trial

Labcorp (LH) 10K Form and Latest SEC Filings 2026

Labcorp logo
$253.99 -4.06 (-1.57%)
Closing price 03:59 PM Eastern
Extended Trading
$254.13 +0.14 (+0.06%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Labcorp SEC Filings & Recent Activity

Labcorp (NYSE:LH) has submitted 911+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Labcorp's financial statements. The most recent filing was a Form 144 submitted on May 6, 2026.

Form 4
LABCORP HOLDINGS INC. Reports Ownership Change on Mar. 30, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Labcorp Files Current Report on Apr. 30, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Labcorp Files Quarterly Report on May. 4, 2026

The 10-Q contains Labcorp's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Labcorp SEC Filing History

Browse Labcorp's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/06/2026 9:40 AM
Labcorp (920148) Subject
van der Vaart Sandra D (1537208) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2026 1:10 PM
Labcorp (920148) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2026 5:57 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 9:47 AM
Labcorp (920148) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/10/2026 11:10 AM
Labcorp (920148) Filer
Form DEFA14A
04/10/2026 11:15 AM
Labcorp (920148) Filer
Form ARS
04/10/2026 11:01 AM
Labcorp (920148) Filer
Form DEF 14A
04/09/2026 5:54 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 3:21 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2026 11:46 AM
Labcorp (920148) Issuer
Oyegunwa Akinbolade (2042869) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:47 AM
Labcorp (920148) Issuer
Summy Amy B. (1805303) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:49 AM
Labcorp (920148) Issuer
van der Vaart Sandra D (1537208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:52 AM
Labcorp (920148) Issuer
Vaughn Bryan T (2103999) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:54 AM
Labcorp (920148) Issuer
Wilkinson Peter J (1398138) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:55 AM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:56 AM
Labcorp (920148) Issuer
Schroeder Mark S (1793112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:57 AM
GRAHAM ANITA Z (1206814) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:58 AM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:42 AM
Bailey Megan D. (1975682) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:43 AM
Kyle Kathryn W (2103996) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 11:44 AM
Labcorp (920148) Issuer
Meltzer Jonathan C (2103998) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 9:40 AM
Labcorp (920148) Subject
Meltzer Jonathan C (2103998) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2026 10:46 AM
Labcorp (920148) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/20/2026 4:01 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2026 7:57 AM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 11:23 AM
Labcorp (920148) Subject
Schechter Adam H (1376841) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 9:41 AM
Labcorp (920148) Issuer
van der Vaart Sandra D (1537208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 8:40 AM
Labcorp (920148) Subject
van der Vaart Sandra D (1537208) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:25 AM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2026 12:50 PM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2026 12:51 PM
Labcorp (920148) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2026 8:13 AM
Labcorp (920148) Issuer
Wilkinson Peter J (1398138) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 5:54 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 11:58 AM
Labcorp (920148) Issuer
Wengel Kathryn E (1745955) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:03 PM
Labcorp (920148) Issuer
Rothman Paul (1601332) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:07 PM
Bailey Megan D. (1975682) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:08 PM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:09 PM
GRAHAM ANITA Z (1206814) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:10 PM
Kyle Kathryn W (2103996) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:11 PM
Labcorp (920148) Issuer
Meltzer Jonathan C (2103998) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:12 PM
Labcorp (920148) Issuer
Oyegunwa Akinbolade (2042869) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:13 PM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:13 PM
Labcorp (920148) Issuer
Schroeder Mark S (1793112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:14 PM
Labcorp (920148) Issuer
van der Vaart Sandra D (1537208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:15 PM
Labcorp (920148) Issuer
Vaughn Bryan T (2103999) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:16 PM
Labcorp (920148) Issuer
Wang Julia Aijun (1860279) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:17 PM
Labcorp (920148) Issuer
Wilkinson Peter J (1398138) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 12:19 PM
Labcorp (920148) Issuer
Summy Amy B. (1805303) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 11:47 AM
ANDERSON KERRII B (1227159) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2026 11:48 AM
Davis Jeffrey A. (1648477) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:32 PM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:34 PM
Bailey Megan D. (1975682) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:35 PM
GRAHAM ANITA Z (1206814) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:36 PM
Labcorp (920148) Issuer
Summy Amy B. (1805303) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:39 PM
Labcorp (920148) Issuer
Oyegunwa Akinbolade (2042869) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:40 PM
Labcorp (920148) Issuer
Wilkinson Peter J (1398138) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:41 PM
Labcorp (920148) Issuer
Wang Julia Aijun (1860279) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:42 PM
Labcorp (920148) Issuer
Vaughn Bryan T (2103999) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:43 PM
Kyle Kathryn W (2103996) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:44 PM
Labcorp (920148) Issuer
Meltzer Jonathan C (2103998) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 2:45 PM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:03 AM
Kliphouse Kirsten Marie (1948684) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:05 AM
Labcorp (920148) Issuer
NEUPERT PETER M (1237566) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:07 AM
Labcorp (920148) Issuer
Parham Richelle P (1550078) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:08 AM
Labcorp (920148) Issuer
Wengel Kathryn E (1745955) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:09 AM
Labcorp (920148) Issuer
Sampson John H (2110483) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:24 AM
Labcorp (920148) Issuer
Rothman Paul (1601332) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:28 AM
Kong Garheng (1435183) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:00 AM
Bulto Carulla Victor (2098937) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 10:02 AM
Davis Jeffrey A. (1648477) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 9:59 AM
ANDERSON KERRII B (1227159) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:49 AM
Labcorp (920148) Subject
Meltzer Jonathan C (2103998) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2026 11:59 AM
Labcorp (920148) Subject
Schechter Adam H (1376841) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2026 8:04 AM
Labcorp (920148) Issuer
Sampson John H (2110483) Reporting
Form 3
Initial statement of beneficial ownership of securities  
02/10/2026 2:13 PM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:15 PM
Labcorp (920148) Issuer
Oyegunwa Akinbolade (2042869) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:18 PM
Caveney Brian J (1717915) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:34 PM
Labcorp (920148) Issuer
Wang Julia Aijun (1860279) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 1:58 PM
Bailey Megan D. (1975682) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:00 PM
Labcorp (920148) Issuer
Summy Amy B. (1805303) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:01 PM
GRAHAM ANITA Z (1206814) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:02 PM
Kyle Kathryn W (2103996) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2026 2:04 PM
Labcorp (920148) Issuer
Meltzer Jonathan C (2103998) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2026 12:30 PM
Labcorp (920148) Subject
Meltzer Jonathan C (2103998) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2026 7:34 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2026 3:15 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 5:53 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2026 8:56 AM
Kyle Kathryn W (2103996) Reporting
Labcorp (920148) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/12/2026 9:04 AM
Labcorp (920148) Issuer
Meltzer Jonathan C (2103998) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/12/2026 8:50 AM
Labcorp (920148) Issuer
Vaughn Bryan T (2103999) Reporting
Form 3
Initial statement of beneficial ownership of securities  
12/30/2025 3:17 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2025 3:03 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2025 3:23 PM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2025 12:35 PM
Bulto Carulla Victor (2098937) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 6:32 AM
Bulto Carulla Victor (2098937) Reporting
Labcorp (920148) Issuer
Form 3
Initial statement of beneficial ownership of securities  
11/24/2025 7:33 AM
Labcorp (920148) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2025 7:47 AM
Labcorp (920148) Issuer
Schechter Adam H (1376841) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 5:54 AM
Labcorp (920148) Subject
Schechter Adam H (1376841) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2025 12:35 PM
Labcorp (920148) Issuer
Oyegunwa Akinbolade (2042869) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 12:43 PM
Bailey Megan D. (1975682) Reporting
Labcorp (920148) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Labcorp SEC Filings - Frequently Asked Questions

Labcorp (LH) has submitted 911+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Labcorp's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Labcorp's financial statements page.

The most recent filing was a Form 144 submitted on May 6, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:LH) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners